BON
Bon Natural Life Limited (BON) Risks & Opportunities Analysis (2026)
No material changes this month.
Risks
Extremely elevated net debt to EBITDA and negative interest coverage leave BON far more exposed to refinancing and covenant pressure than most peers with positive earnings coverage.
A 512-day cash conversion cycle, driven by 475 days of inventory and 226 days of receivables, ties up working capital more severely than leaner peers and constrains flexibility.
Negative interest coverage versus peers with positive operating earnings means any demand or margin softness can translate into faster balance-sheet stress and weaker capital access.
Current and quick ratios near 1.7x and 1.0x provide only modest liquidity protection, leaving BON less resilient than better-capitalized peers if trading conditions tighten.
Opportunities
If BON can normalize inventory and receivables turns, the unusually large working-capital release could improve cash generation more than peers with already efficient cycles.
The current ratio above 1.0x suggests near-term liquidity is adequate, giving BON more room than distressed peers to absorb volatility while it works through operating pressure.
Overall Score
BON’s forward positioning is constrained by extreme leverage, negative interest coverage, and very weak working-capital efficiency, while only limited liquidity and potential cash-release upside temper the profile.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Bon Natural Life Limited. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
